NCT06965816View on ClinicalTrials.gov

Using Neuroimaging to Early Diagnose Alzheimer's Disease Through Hippocampal Atrophy Assessment

CompletedOBSERVATIONAL

Enrollment

85

Participants

Timeline

Start Date

November 24, 2022

Primary Completion Date

May 24, 2023

Study Completion Date

May 24, 2023

Conditions

Alzheimer's DiseaseHippocampusBrain AtrophyMagnetic Resonance ImagingLeukoaraiosisNeurodegenerative DiseasesCortical and Subcortical Atrophy

Trial Locations (1)

Unknown

France, Saint-Denis

All Listed Sponsors

lead

Centre Hospitalier de Saint-Denis

OTHER